Pharmaron Renews Three-Year Research Services Agreement With Newbay Technology

PUBT · 3d ago
Pharmaron Renews Three-Year Research Services Agreement With Newbay Technology
  • Pharmaron Beijing entered a renewed research services framework agreement with Newbay Technology on October 27, 2026.
  • The agreement runs from January 1, 2027, through December 31, 2029, covering laboratory, manufacturing and clinical research services.
  • Annual service fee caps are RMB 50 million for 2027, falling to RMB 40 million each in 2028 and 2029.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmaron Beijing Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261027-12384672), on October 27, 2026, and is solely responsible for the information contained therein.